Medicare Coverage For Non-IND Drug Trials Should Continue – PhRMA & BIO

The drug industry is pushing for continued Medicare coverage of pharmaceutical research that is not subject to the FDA's investigational new drug requirements as CMS begins to revise its Medicare clinical trials policy